Objective. Red blood cell distribution width (RDW) is a biomarker quantifying the variability of red blood cell size in peripheral blood. Elevated RDW has been found to be an independent prognostic factor for cardiovascular events. SSc is characterized by generalized micro-and macroangiopathy. Our aim was to investigate RDW as a potential biomarker for the assessment of the severity of vascular involvement.
Introduction
Red blood cell distribution width (RDW) is a biomarker that quantifies variability in red blood cell size, pointing to the level of anisocytosis in the complete blood count. The normal range of RDW is between 11.5 and 14.5% [1] . Elevated RDW can be present during inflammation and nutritional deficiencies, and co-morbidities including renal failure also influence RDW [24] . RDW is also a predictor of survival in idiopathic pulmonary arterial hypertension (PAH) [5, 6] and an independent prognostic risk factor in cardiovascular or cerebrovascular events in the general population and in patients with heart failure, coronary heart disease or peripheral atherosclerosis [79] . Furthermore, high RDW is closely associated with the risk of carotid artery atherosclerosis in patients with hypertension [10] . Elevated values of RDW can be found in thalassaemia and in other anaemias, including early stage iron, folate or vitamin B 12 deficiency, and also can be present in some types of hepatopathy [1, 2, 9] .
SSc is a systemic autoimmune disease with generalized obliterative arterial vasculopathy and microvascular lesions [11] . There is a wide spectrum of organ manifestations that may potentially influence RDW in patients with SSc, including PAH, left diastolic heart dysfunction, vascular lesion of the kidney (scleroderma renal crisis) and peripheral arterial disease. Late-stage lung and skin fibrosis may also coincide with impaired microcirculation [1216] . These particular abnormalities are potential factors that may influence RDW in SSc. Furthermore, malabsorption may cause iron or B 12 deficiency. With others, we have previously demonstrated that inflammation (increased CRP) is an unfavourable prognostic factor in patients with SSc [12, 17] .
We hypothesized that RDW may associate with multiple pathogenetic factors in SSc and may prove useful as a severity and/or prognostic marker in this disease [2, 15, 16, 18] . The aim of this study was to analyse the associations of increased RDW and the presence of different organ manifestations in patients with SSc. We also investigated whether changes in RDW during follow-up are linked to progression of different manifestations of SSc.
Patients and methods
One hundred and sixty-eight consecutive Hungarian (Caucasian) patients (147 females and 21 males; 62 with dcSSc, 106 with lcSSc) were included in the study (Table 1) . At the baseline examination the mean age of patients with SSc was 55.1 years (S.D. 12.7), the mean disease duration was 8.1 years (S.D. 7.2) and the mean follow-up was 6.8 years (S.D. 4.0). Patients were divided into diffuse and limited cutaneous subsets by the criteria of LeRoy et al. [19] . During the follow-up, the DMARD treatment of patients had not changed significantly.
Four deaths caused by SSc were recorded during the investigative 1-year period. Six patients were lost to follow-up and one of died for reasons other than SSc.
At baseline and after 1 year, pulmonary function tests, echocardiography and the Scleroderma Study Group Activity Index (EScSG) [20] were performed within 6 weeks of the blood test. Clinical characteristics included the presence of subcutaneous calcinosis, telangiectasia, skin hypo-/ hyperpigmentation and active skin ulcers. Modified Rodnan skin score (MRSS) [21] , ESR, CRP, ANA, ACA, anti-DNA topoisomerase I (anti-topo I) and anti-CCP autoantibodies were also measured. Haematological parameters and red blood cell indices, including RDW, mean cell volume, mean haemoglobin concentration and mean corpuscular haemoglobin concentration, were measured using a Siemens Advia 120 Haematology System (Bayer Diagnostic, Tarrytown, NY, USA).
Internal organ manifestations were recorded according to a standard protocol as previously described [13] . Each early diffuse SSc case and patients having a forced vital capacity (FVC) <80% of the predicted value underwent high-resolution CT of the lungs for the assessment of interstitial lung disease. Right heart catheterization was performed according to the clinical guidelines to verify the diagnosis of PAH [13, 14] . The measurements were done at rest as well as during physical exertion (a 3-min bench-fly physical stress test with 1 kg dumbbells). The diagnosis was established based on the mean pulmonary artery pressure (mPAP) values using the modified Venice criteria [i.e. mPAP >25 mmHg at rest or >30 mmHg on exertion in the absence of an increase in the pulmonary capillary wedge pressure (<15 mmHg)]. Left ventricular diastolic abnormality, pericarditis and conduction disturbances were also recorded based on ECG and echocardiography results.
Severe micro-/macrovascular involvement was considered in cases with active digital ulcers, amputation due to peripheral scleroderma-related vascular disease, cardiac conduction disturbance/arrhythmia, left ventricular ejection fraction <50%, PAH or scleroderma renal crisis. We performed a cross-sectional investigation of 93 patients with primary RP (85 females and 8 males) [22] who served as controls for the study (Table 1) . Forty healthy subjects (35 females and 5 males) were also investigated; their mean age was 53.7 years (S.D. 10.9) ( Table 1 ). The study was approved by the Regional Ethics Committee (approval no. 15-838/2006 ) and all patients and controls gave informed consent. The research was done in compliance with the Declaration of Helsinki.
Statistical analysis
The distribution of values was assessed by using the KolmogorovSmirnov test. Comparison of RDW values between the subgroups was performed by using the MannWhitney U test. Correlations between RDW and the other measured variables were determined using Spearman's correlation coefficient.
Cases were stratified into three groups according to the RDW tertiles (<13.6%, 13.614.6% and >14.6%) and clinically relevant differences were evaluated by the KruskalWallis analysis of variance (ANOVA) test or the chi-square test, as appropriate. Comparisons between RDW values and differences between baseline and 1-year follow-up values were analysed using the Wilcoxon signed-rank test. An independent sample t-test was used to compare the change in values of different clinical parameters between the group with >5% increase in RDW and <5% increase in RDW during the 1-year follow-up.
To explore which factors are most influential in RDW changes during the follow-up, multiple linear regression with stepwise selection was used. Statistical analyses were performed using SPSS Statistics version 20.0 (IBM, Armonk, NY, USA).
Results
Demographic data and general clinical characteristics of the patients are shown in Table 1 . At baseline, the median RDW was 14.2% (25th75th percentiles 13.514.8%) in patients with SSc, 13.9% (13.414.4%) in patients with primary RP and 13.55% (13.213.8%) in the healthy group. The average RDW was higher in the SSc group than in the primary RP group (P < 0.05) or in healthy subjects (P < 0.01) (Fig. 1) .
RDW in different clinical subsets and in cases with extensive vascular involvement
The median value of RDW was significantly higher in the dcSSc group compared with the lcSSc group: 14.6% (25th75th percentiles 13.615.3%) and 14.0% (13.314.6%), respectively (P < 0.05). There was no difference between the RDW values of patients with primary RP and lcSSc ( Fig. 1 and Table 2 ). Significantly more patients with dcSSc were found in the group with RDW >14.6% than in the normal range or in the <13.6% group (Table 3) . Furthermore, there was a significant difference in RDW in the anti-topo Ipositive and negative subgroups (P < 0.05), but no similar difference was found with the ACA-positive cases (Table 2) .
There was a significant difference (P < 0.05) in the median RDW values over the 1-year follow-up period between patients with (n = 70) and without (n = 98) clinically significant severe micro-/macrovascular involvement (for a definition, see Patients and methods) ( Table 2 ).
RDW and inflammatory markers A significant correlation was found between RDW and inflammatory markers, including both CRP (r baseline = 0.156, P < 0.05; r 1-year = 0.276, P < 0.01), ESR (r baseline = 0.234, P < 0.01; r 1-year = 0.156, P = 0.05). The most elevated inflammatory parameters were present in the tertile group with the highest RDW ( Table 2) . We detected a negative correlation between RDW and levels of albumin (r baseline = À0.293, P < 0.01; r 1-year = À0.281, P < 0.01) and creatine kinase (CK) (r baseline = À0.233, P < 0.01; r 1 year = À0.309, P < 0.01), although both parameters remained within the normal range. Both at baseline and the 1-year follow-up, RDW values showed a significant correlation with the EScSG activity index [20] (r baseline = 0.191, P < 0.05; r 1-year = 0.202, P < 0.05) (n = 144) (Table 3) .
RDW and respiratory markers
The FVC (r baseline = À0.229, P < 0.01; r 1-year = À0.262, P < 0.01) and diffusing capacity of the lung for carbon monoxide (DLCO) (r baseline = À0.283, P < 0.01; r 1 year = À0.271, P < 0.01) showed a negative correlation with RDW over the follow-up. The patients in the highest (>14.6%) RDW tertile had significantly the lowest values of FVC and DLCO 
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RDW as a biomarker in systemic sclerosis compared with patients in the normal range and in the lowest (<13.6%) tertile (Table 3) .
The 20 dcSSc patients with interstitial lung disease (FVC <70%) exhibited a median RDW of 14.6% (25th75th percentiles 14.015.7%). The two cases with the lowest values in lung function tests (FVC <50%) showed the highest values of RDW (15.3% and 16.8%, respectively).
Clinical significance of increase in RDW
In those patients whose RDW increased 55% during the observation period of 1 year (n = 54), we observed an 8.9% (mean 1.96, CI 0.018, 3.891) decrease of the LVEF (mean LVEF baseline = 64.3%, LVEF 1-year = 59.1%, P < 0.05). In the group of patients (n = 104) with an RDW increase of <5%, the LVEF changed only slightly (only 0.9% mean elevation) (mean 2.34, CI 0.39, 4.98; mean LVEF baseline 62.5%, LVEF 1-year 63.0%). There was a significant difference (P < 0.05) between the change in LVEF observed in the two groups (i.e. patients with an RDW increase 55% and those with an RDW increase of <5%).
Similar results were observed in the DLCO values. There was a 7% (mean 4.33, CI 1.77, 6.88) decrease in the DLCO values in the group of patients with a 55% RDW increase (mean DLCO baseline 61.8%, DLCO 1-year 57.5%), however, there was only a 2% (mean 2.63, CI 0.48, 4.78) decrease in the other group (mean DLCO baseline 64.9%, DLCO 1-year 62.4%). There was also a significant difference (P < 0.01) between the change in DLCO observed in the two groups (i.e. patients with an RDW increase of 55% vs those with an RDW decrease <5%).
To analyse the changes in values of different clinical factors that may significantly influence RDW changes during follow-up we used multiple linear regression with stepwise selection. Based on these data, increase in RDW was independently associated with decrease in LVEF, DLCO and serum level of CK (Table 4) .
Discussion
Recently several studies have evaluated the clinical significance of RDW as a prognostic factor in patients with cardiovascular diseases, active or chronic inflammation, RA, breast cancer and in elderly patients [2, 3, 23, 24] . Several potential mechanisms may account for the association of RDW with clinical outcomes, since RDW may represent an integrative measure of multiple pathological processes, including ineffective erythropoiesis, inflammation, pulmonary and renal dysfunction and impaired nutritional state [2, 4, 25]. The molecular basis of the above-mentioned associations has been mainly attributed to the ability of RDW to reliably reflect an increase in the levels of circulating cytokines, such as IL-6 and TNF-a, and other factors such as hepcidin [2, 3, 25, 26] . This is the first report showing the importance of RDW in SSc. This particular disorder is characterized by widespread vascular involvement, and in cases with advanced disease also with inflammation, malabsorption and anaemia with a complex aetiology [11, 16, 15, 18] . Our study indicates that increased RDW predominantly reflects pronounced inflammation and the extent of vascular involvement in patients with SSc. The mean values of RDW were higher in the dcSSc and anti-topopositive group (Table 2) , who have generally more extensive vascular involvement and also skin and internal organ manifestations [12, 13] . In recent studies, greater RDW consistently correlated with shorter survival in acute and chronic heart failure, myocardial infarction and PAH [5, 6, 9, 10].
In patients with vascular impairment we consistently failed to find elevated RDW (e.g. in PAH or cardiac involvement), probably because the subclinical changes without any clinically obvious presentation do not cause abnormal RDW (Tables 2 and 3) . When we tested patients having at least one of the clinically significant macro-and/or microvascular organ manifestations (PAH, LVEF <50%, conduction disturbance/arrhythmia, active digital ulcers, scleroderma renal crisis or amputation due to severe peripheral arterial Multiple linear regression analysis in 158 patients with SSc in 1-year follow-up. Statistically significant P-values (P < 0.05) are in bold. RDW: red cell distribution width; ÁLVEF: change in left heart ejection fraction; ÁCK: change in serum level of creatine kinase; ÁDLCO: change in the diffusing capacity of the lung for carbon monoxide.
www.rheumatology.oxfordjournals.org disease) we found a significantly higher mean RDW compared with cases without major vascular symptoms ( Table 2 ), indicating that this particular marker may be useful for the identification of patients with widespread vascular involvement. In our investigation of SSc patients, FVC and DLCO consistently showed a negative correlation with RDW over the follow-up period. It has been previously shown that lung disease coincides with microvascular lesions on nailfold capillaroscopy [11, 16, 27] . Similar findings are seen in other chronic lung diseases. A negative correlation of RDW with FVC and FEV1/FVC was demonstrated in patients with chronic obstructive pulmonary diseases [27, 28] . A US population-based study showed an inverse relationship between RDW and lung function [29] .
The small number of patients with severe interstitial lung disease may explain why we did not find a remarkable increase in RDW in these particular cases with lung fibrosis. Based on the high RDW values of the two patients with severe lung fibrosis (FVC <50%), further studies are required to clarify the role of RDW in patients with extensive interstitial lung involvement.
RDW values were also correlated with markers of inflammation (CRP, ESR), malabsorption (albumin) and the EScSG. Activity of SSc involves ongoing vascular process and inflammation, accompanied by impairment of erythropoiesis, therefore RDW may be a potential marker for disease activity. Further investigations are required to clarify whether RDW is a useful marker of disease activity in SSc. Furthermore, an increasing RDW may be clinically useful as a biomarker associated with decreasing LVEF and DLCO, indicating impairment of cardiovascular function and disease progression [30] , although the small number of patients with severe cardiovascular abnormalities and several independent interrelated factors are substantial limitations in our study. Certainly further large-scale investigations are required to clarify the role of RDW in different clinical subsets of SSc patients with cardiorespiratory manifestations. Serum levels of CK showed an independent association and statistically negative correlation with RDW values over the follow-up period. Because this particular parameter remained within the normal range throughout the study, the clinical significance seems to be questionable.
One of the limitations of our study was the relatively short time frame of the investigation, and thus the lack of information on whether RDW might serve as a longterm prognostic factor. Also, a caveat of this study is that we did not have data on the levels of folic acid, vitamin B 12 or iron, nor on the reticulocyte count, erythropoietin levels and haemolysis test results, all of which might affect RDW values. Those variables were investigated among our patients only when there were clinical indications to do so.
The strength of the presented data is the described relationship of increasing RDW and decreasing cardiopulmonary function. Measurement of RDW is easily available, inexpensive and might contribute in monitoring cardiorespiratory functional capacity in patients with SSc.
The observation of increased RDW could be useful as a marker for individual guidance of both pharmacological and non-pharmacological therapy. Further observation of RDW in quarterly laboratory evaluations may reveal more detail or further impact on therapy decisions in patients with SSc.
Rheumatology key messages
. Red blood cell distribution width (RDW) is an integrative measure of multiple pathological processes in scleroderma. . An increase in RDW may indicate a worsening of cardiopulmonary manifestations in patients with SSc.
